@misc{indiciae94cbff2caef5,
  title = {Low seroprevalence of neutralizing antibodies to gorilla adenovirus 32 (GRAd32) in southern African populations supports evaluation of this vector platform for HIV vaccine development},
  author = {Mkhize, N. N. and patjane, A. and Shusha, N. and Welsh, A. and Hermanus, T. and Kgagudi, P. and Motlou, T. and Bekker, L.-G. and Gray, G. and Garrett, N. and Fairlie, L. and Sigal, A. and Burgers, W. and Mangwaku, T. and Makadzange, T. and Colloca, S. and Folgori, A. and Moyo-Gwete, T. and Gentile, M. and Capone, S. and Moore, P. L.},
  year = {2026},
  doi = {10.64898/2026.05.23.726423},
  url = {https://www.biorxiv.org/content/10.64898/2026.05.23.726423v1},
  note = {Source identifier: 10.64898/2026.05.23.726423}
}